• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同重建参数对评估心脏转甲状腺素淀粉样变性的 Tc-DPD SPECT/CT 定量值的影响。

The impact of different reconstruction parameters on quantitative Tc-DPD SPECT/CT values in the assessment of cardiac transthyretin amyloidosis.

机构信息

Department of Nuclear Medicine, Bern University Hospital, Inselspital, University of Bern, Freiburgstrasse 18, Bern, 3011, Switzerland.

Department of Cardiology, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland.

出版信息

Int J Cardiovasc Imaging. 2024 Nov;40(11):2317-2324. doi: 10.1007/s10554-024-03231-7. Epub 2024 Sep 18.

DOI:10.1007/s10554-024-03231-7
PMID:39292397
Abstract

AIM

To assess in a phantom and in a clinical study the influence of different reconstruction parameters on quantitative SPECT/CT values in the assessment of cardiac transthyretin amyloidosis (ATTR-CA).

METHOD

A hybrid SPECT/CT camera with a proprietary software for SPECT/CT-based quantification of myocardial uptake of Tc-DPD was used. Images were reconstructed with 6 different protocols, differing in iterations, subset and Gaussian filter. Quantitative values were tested in phantom and clinical studies across different reconstruction protocols. Values were automatically calculated both as kBq/ml and as maximum, mean and peak standardized uptake value (SUV).

RESULTS

The standard parameters provided by the manufacturer (reconstruction 1) yielded higher accuracy in quantifying, with measuring 97.1% of the expected activity in the phantom. Reconstructions with higher Gaussian filter caused a systematic underestimation of quantified values of 27.2% (p < 0.01). Results were replicated in the clinical study consisting of 155 patients with suspected ATTR-CA, wherein changing the number of iterations and subsets was not associated with a statistically significant difference in quantitative values compared to reconstruction 1, while a higher Gaussian filter caused inaccurate quantification with up to 24% of difference measured.

CONCLUSION

Different reconstruction parameters can impact quantitative values on Tc-DPD SPECT/CT. Therefore, parameters should be maintained consistently across different acquisitions and different centres.

摘要

目的

在体模和临床研究中评估不同重建参数对心脏转甲状腺素淀粉样变性(ATTR-CA)评估中 SPECT/CT 定量值的影响。

方法

使用配备专有软件的 SPECT/CT 混合相机,用于基于 SPECT/CT 定量评估 Tc-DPD 在心肌摄取中的应用。使用 6 种不同的协议进行图像重建,这些协议在迭代、子集和高斯滤波器方面有所不同。在不同的重建协议中,在体模和临床研究中对定量值进行了测试。值自动以 kBq/ml 和最大、平均和峰值标准化摄取值(SUV)计算。

结果

制造商提供的标准参数(重建 1)在定量方面具有更高的准确性,在体模中测量到 97.1%的预期活动。具有更高高斯滤波器的重建会导致定量值系统低估 27.2%(p<0.01)。该结果在包含 155 名疑似 ATTR-CA 患者的临床研究中得到了复制,其中改变迭代次数和子集与重建 1 相比,定量值没有统计学差异,而更高的高斯滤波器会导致不准确的定量,测量差异高达 24%。

结论

不同的重建参数会影响 Tc-DPD SPECT/CT 的定量值。因此,在不同的采集和不同的中心之间,参数应保持一致。

相似文献

1
The impact of different reconstruction parameters on quantitative Tc-DPD SPECT/CT values in the assessment of cardiac transthyretin amyloidosis.不同重建参数对评估心脏转甲状腺素淀粉样变性的 Tc-DPD SPECT/CT 定量值的影响。
Int J Cardiovasc Imaging. 2024 Nov;40(11):2317-2324. doi: 10.1007/s10554-024-03231-7. Epub 2024 Sep 18.
2
DPD Quantification in Cardiac Amyloidosis: A Novel Imaging Biomarker.心肌淀粉样变中 DPD 的定量:一种新型的影像学生物标志物。
JACC Cardiovasc Imaging. 2020 Jun;13(6):1353-1363. doi: 10.1016/j.jcmg.2020.03.020.
3
Quantitative Tc-DPD SPECT/CT in patients with suspected ATTR cardiac amyloidosis: Feasibility and correlation with visual scores.定量锝-二膦酸盐单光子发射计算机断层扫描/计算机断层扫描在疑似转甲状腺素蛋白淀粉样变心肌病患者中的应用:可行性及与视觉评分的相关性
J Nucl Cardiol. 2020 Oct;27(5):1456-1463. doi: 10.1007/s12350-019-01893-8. Epub 2019 Sep 19.
4
Prognostic Value of [Tc]Tc-DPD Quantitative SPECT/CT in Patients with Suspected and Confirmed Amyloid Transthyretin-Related Cardiomyopathy and Preserved Left Ventricular Function.疑似和确诊转甲状腺素蛋白相关淀粉样变性心肌病伴左心室射血分数保留患者中 [Tc]Tc-DPD 定量 SPECT/CT 的预后价值。
J Nucl Med. 2024 Jun 3;65(6):944-951. doi: 10.2967/jnumed.123.266926.
5
An optimized imaging protocol for [Tc]Tc-DPD scintigraphy and SPECT/CT quantification in cardiac transthyretin (ATTR) amyloidosis.用于心脏转甲状腺素(ATTR)淀粉样变性的 [Tc]Tc-DPD 闪烁显像和 SPECT/CT 定量的优化成像方案。
J Nucl Cardiol. 2021 Dec;28(6):2483-2496. doi: 10.1007/s12350-021-02715-6. Epub 2021 Jul 30.
6
Monitoring tafamidis treatment with quantitative SPECT/CT in transthyretin amyloid cardiomyopathy.用定量 SPECT/CT 监测转甲状腺素蛋白淀粉样心肌病中的塔法米迪治疗。
Eur Heart J Cardiovasc Imaging. 2023 Jul 24;24(8):1019-1030. doi: 10.1093/ehjci/jead030.
7
Quantitative Tc-pyrophosphate myocardial uptake: Changes on transthyretin stabilization therapy.定量 Tc-焦磷酸盐心肌摄取:转甲状腺素蛋白稳定治疗的变化。
J Nucl Cardiol. 2024 Sep;39:102019. doi: 10.1016/j.nuclcard.2024.102019. Epub 2024 Aug 10.
8
Cardiac transthyretin amyloidosis Tc-DPD SPECT correlates with strain echocardiography and biomarkers.心肌转甲状腺素淀粉样变 Tc-DPD SPECT 与应变超声心动图和生物标志物相关。
Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):1822-1832. doi: 10.1007/s00259-020-05144-8. Epub 2020 Dec 26.
9
Deep Learning-Enabled Quantification of Tc-Pyrophosphate SPECT/CT for Cardiac Amyloidosis.深度学习在 Tc-焦磷酸盐 SPECT/CT 心肌淀粉样变性定量中的应用。
J Nucl Med. 2024 Jul 1;65(7):1144-1150. doi: 10.2967/jnumed.124.267542.
10
Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis.(99m)Tc-DPD 闪烁显像在遗传性转甲状腺素蛋白相关心脏淀粉样变性的诊断和预后中的作用。
JACC Cardiovasc Imaging. 2011 Jun;4(6):659-70. doi: 10.1016/j.jcmg.2011.03.016.

引用本文的文献

1
Multi-modality artificial intelligence-based transthyretin amyloid cardiomyopathy detection in patients with severe aortic stenosis.基于多模态人工智能的严重主动脉瓣狭窄患者转甲状腺素蛋白淀粉样心肌病检测
Eur J Nucl Med Mol Imaging. 2025 Jan;52(2):485-500. doi: 10.1007/s00259-024-06922-4. Epub 2024 Sep 23.

本文引用的文献

1
Characteristics of Smoothing Filters to Achieve the Guideline Recommended Positron Emission Tomography Image without Harmonization.在不进行归一化的情况下实现指南推荐的正电子发射断层扫描图像的平滑滤波器特性
Asia Ocean J Nucl Med Biol. 2018 Winter;6(1):15-23. doi: 10.22038/aojnmb.2017.26684.1186.